• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诊断、治疗和披露:单基因糖尿病登记处参与者面临挑战的定性探讨。

Diagnosis, treatment and disclosure: A qualitative exploration of participant challenges in a Monogenic Diabetes Registry.

机构信息

Department of Medicine, The University of Chicago, Chicago, IL.

Department of Medicine, The University of Chicago, Chicago, IL.

出版信息

Genet Med. 2023 Apr;25(4):100019. doi: 10.1016/j.gim.2023.100019. Epub 2023 Jan 20.

DOI:10.1016/j.gim.2023.100019
PMID:36681871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10620612/
Abstract

PURPOSE

Maturity-onset diabetes of the young (MODY) represents a heterogenous group of monogenic diabetes. Despite its autosomal dominant inheritance, many MODY participants in the University of Chicago Monogenic Diabetes Registry have no family members enrolled. We aimed to gather data on the Registry participants' experiences in (1) receipt of an accurate diagnosis, (2) decisions regarding disclosure of their MODY genetic test results with biological relatives, and (3) recommendations toward our Registry's processes and outreach.

METHODS

We conducted 20 one-on-one semistructured interviews with adult Registry participants.

RESULTS

All participants found navigating the health care system challenging because of the providers' unfamiliarity with MODY and dismissal of its importance post diagnosis. All had shared their results with at least 1 relative, however many found their relatives resistant to engaging with their providers. Participants wanted to receive targeted information on their condition and connect with other participants who have faced similar diagnostic and treatment challenges.

CONCLUSION

Our results demonstrate that our probands faced resistance to reclassification of their diabetes from both health care providers and relatives. In an effort to improve cascade testing, the Registry is designing a portal to facilitate participant-research team communication and provide additional supports for participants to involve family members in testing.

摘要

目的

青年发病型糖尿病(MODY)代表了一组异质性的单基因糖尿病。尽管它是常染色体显性遗传,但芝加哥大学单基因糖尿病登记处的许多 MODY 参与者没有登记的家庭成员。我们旨在收集登记处参与者在以下方面的经验数据:(1)获得准确诊断;(2)决定是否向生物亲属透露其 MODY 基因检测结果;(3)对我们登记处的流程和外展提出建议。

方法

我们对 20 名成年登记处参与者进行了 20 次一对一的半结构化访谈。

结果

所有参与者都发现由于提供者对 MODY 不熟悉以及在诊断后对其重要性的忽视,他们在就医过程中遇到了挑战。所有人都至少与 1 名亲属分享了他们的结果,但许多人发现他们的亲属不愿与他们的提供者接触。参与者希望获得有关其病情的针对性信息,并与其他面临类似诊断和治疗挑战的参与者联系。

结论

我们的结果表明,我们的先证者在从医疗保健提供者和亲属那里重新分类他们的糖尿病方面都面临阻力。为了改进级联测试,登记处正在设计一个门户,以促进参与者-研究团队之间的沟通,并为参与者提供更多的支持,以便让家庭成员参与测试。

相似文献

1
Diagnosis, treatment and disclosure: A qualitative exploration of participant challenges in a Monogenic Diabetes Registry.诊断、治疗和披露:单基因糖尿病登记处参与者面临挑战的定性探讨。
Genet Med. 2023 Apr;25(4):100019. doi: 10.1016/j.gim.2023.100019. Epub 2023 Jan 20.
2
Maturity onset diabetes of the young due to variants in Croatia.因克罗埃西亚的变异导致的青年发病型糖尿病。
Biochem Med (Zagreb). 2018 Jun 15;28(2):020703. doi: 10.11613/BM.2018.020703. Epub 2018 Apr 15.
3
Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry.通过芝加哥大学单基因糖尿病登记处进行的十多年研究对诊断和治疗的见解。
Front Clin Diabetes Healthc. 2021 Nov;2. doi: 10.3389/fcdhc.2021.735548. Epub 2021 Nov 5.
4
Patient perspectives on the diagnostic journey to a monogenic diabetes diagnosis: Barriers and facilitators.患者对单基因糖尿病诊断诊断之旅的看法:障碍和促进因素。
J Genet Couns. 2020 Dec;29(6):1106-1113. doi: 10.1002/jgc4.1247. Epub 2020 Mar 12.
5
Approach to the Patient with MODY-Monogenic Diabetes.MODY-单基因糖尿病患者的处理方法。
J Clin Endocrinol Metab. 2021 Jan 1;106(1):237-250. doi: 10.1210/clinem/dgaa710.
6
Maturity-onset diabetes of the young in a large Portuguese cohort.葡萄牙一个大型队列中的青年成年型糖尿病
Acta Diabetol. 2023 Jan;60(1):83-91. doi: 10.1007/s00592-022-01980-2. Epub 2022 Oct 8.
7
GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated.美国单基因糖尿病登记处中的GCK-MODY:常被误诊且接受不必要的治疗。
Acta Diabetol. 2016 Oct;53(5):703-8. doi: 10.1007/s00592-016-0859-8. Epub 2016 Apr 22.
8
A genetic diagnosis of maturity-onset diabetes of the young (MODY): experiences of patients and family members.青少年成年起病型糖尿病(MODY)的基因诊断:患者及家庭成员的经历
Diabet Med. 2015 Oct;32(10):1385-92. doi: 10.1111/dme.12742. Epub 2015 Mar 28.
9
Identification of monogenic diabetes in an Australian cohort using the Exeter maturity-onset diabetes of the young (MODY) probability calculator and next-generation sequencing gene panel testing.使用埃克塞特青少年起病的成年型糖尿病(MODY)可能性计算器和下一代测序基因 panel 检测鉴定澳大利亚队列中的单基因糖尿病。
Acta Diabetol. 2024 Feb;61(2):181-188. doi: 10.1007/s00592-023-02193-x. Epub 2023 Oct 9.
10
[Maturity-onset diabetes of the young].青少年成年起病型糖尿病
Ned Tijdschr Geneeskd. 2015;159:A9247.

本文引用的文献

1
Improvements in Awareness and Testing Have Led to a Threefold Increase Over 10 Years in the Identification of Monogenic Diabetes in the U.K.提高认识和检测使得英国在 10 年内单基因糖尿病的检出率增加了两倍。
Diabetes Care. 2022 Mar 1;45(3):642-649. doi: 10.2337/dc21-2056.
2
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022.2. 糖尿病的分类和诊断:2022 年糖尿病医疗护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S17-S38. doi: 10.2337/dc22-S002.
3
Next- generation sequencing is an effective method for diagnosing patients with different forms of monogenic diabetes.下一代测序是诊断不同形式单基因糖尿病患者的有效方法。
Diabetes Res Clin Pract. 2022 Jan;183:109154. doi: 10.1016/j.diabres.2021.109154. Epub 2021 Nov 24.
4
A randomized controlled trial of genetic testing and cascade screening in familial hypercholesterolemia.家族性高胆固醇血症基因检测与级联筛查的随机对照试验
Genet Med. 2021 Sep;23(9):1697-1704. doi: 10.1038/s41436-021-01192-z. Epub 2021 May 26.
5
Facilitated cascade testing (FaCT): a randomized controlled trial.促进级联检测(FaCT):一项随机对照试验。
Int J Gynecol Cancer. 2021 May;31(5):779-783. doi: 10.1136/ijgc-2020-002118. Epub 2020 Dec 18.
6
Approach to the Patient with MODY-Monogenic Diabetes.MODY-单基因糖尿病患者的处理方法。
J Clin Endocrinol Metab. 2021 Jan 1;106(1):237-250. doi: 10.1210/clinem/dgaa710.
7
Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).糖尿病精准医学:美国糖尿病协会(ADA)和欧洲糖尿病研究协会(EASD)的共识报告。
Diabetologia. 2020 Sep;63(9):1671-1693. doi: 10.1007/s00125-020-05181-w.
8
Patient perspectives and experiences with fertilization and genetic testing options.患者对受精及基因检测选项的看法和体验。
Ther Adv Reprod Health. 2020 Apr 16;14:2633494119899942. doi: 10.1177/2633494119899942. eCollection 2020 Jan-Dec.
9
2. Classification and Diagnosis of Diabetes: .2. 糖尿病的分类和诊断: 。
Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31. doi: 10.2337/dc20-S002.
10
Low rates of cascade genetic testing among families with hereditary gynecologic cancer: An opportunity to improve cancer prevention.遗传性妇科癌症家族中级联遗传检测率低:改善癌症预防的机会。
Gynecol Oncol. 2020 Jan;156(1):140-146. doi: 10.1016/j.ygyno.2019.11.005. Epub 2019 Nov 25.